Banner image placeholder
Banner image

Clinical Profiles of Children and Adolescents With Induced Laryngeal Obstruction (ILO) and Exercise Induced Laryngeal Obstruction (EILO)


Journal article


Robert Brinton Fujiki, Bryn K. Olson-Greb, Susan L. Thibeault
Annals of Otology, Rhinology and Laryngology, 2023

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Fujiki, R. B., Olson-Greb, B. K., & Thibeault, S. L. (2023). Clinical Profiles of Children and Adolescents With Induced Laryngeal Obstruction (ILO) and Exercise Induced Laryngeal Obstruction (EILO). Annals of Otology, Rhinology and Laryngology.


Chicago/Turabian   Click to copy
Fujiki, Robert Brinton, Bryn K. Olson-Greb, and Susan L. Thibeault. “Clinical Profiles of Children and Adolescents With Induced Laryngeal Obstruction (ILO) and Exercise Induced Laryngeal Obstruction (EILO).” Annals of Otology, Rhinology and Laryngology (2023).


MLA   Click to copy
Fujiki, Robert Brinton, et al. “Clinical Profiles of Children and Adolescents With Induced Laryngeal Obstruction (ILO) and Exercise Induced Laryngeal Obstruction (EILO).” Annals of Otology, Rhinology and Laryngology, 2023.


BibTeX   Click to copy

@article{robert2023a,
  title = {Clinical Profiles of Children and Adolescents With Induced Laryngeal Obstruction (ILO) and Exercise Induced Laryngeal Obstruction (EILO)},
  year = {2023},
  journal = {Annals of Otology, Rhinology and Laryngology},
  author = {Fujiki, Robert Brinton and Olson-Greb, Bryn K. and Thibeault, Susan L.}
}

Abstract

Purpose: To compare clinical profiles of pediatric patients with Induced Laryngeal Obstruction (ILO), Exercise Induced Laryngeal Obstruction (EILO), and EILO with non-exertion related secondary triggers (EILO+). Methods: A retrospective observational cohort design was employed. Four-hundred and twenty-three patients <18 years of age were identified from the electronic medical record of a large children’s hospital. All patients underwent evaluations with a laryngologist and speech-language pathologist and were diagnosed with EILO/ILO. Patients were divided into 3 groups based on dyspnea triggers reported in initial evaluations. Groups consisted of patients with EILO (N = 281), ILO (N = 30), and EILO+ (N = 112). Patient demographics, EILO/ILO symptoms, endoscopy findings, medical comorbidities, medical history, and EILO/ILO treatment information were extracted and compared across EILO/ILO subtypes. Results: Patients with EILO experienced higher rates of hyperventilation (P < .001), sore throat (P = .023), and chest pain (P = .003). Patients with ILO were significantly younger in age (P = .017) and presented with increased rates of nighttime symptoms (P < .001), globus sensation (P = .008), self-reported reflux symptoms (P = .023), and history of gastrointestinal conditions (P = .034). Patients with EILO+ were more likely to be female (P = .037) and presented with higher prevalence of anxiety (P = .003), ADHD (P = .004), chest tightness (P = .030), and cough (P < .001). Conclusions: Patients with EILO, ILO, and EILO+ present with overlapping but unique clinical profiles. A prospective study is warranted to determine the etiology of these differences and clarify how the efficacy of EILO, ILO, and EILO+ treatment can be maximized. Level of Evidence: 4


Share

Translate to